| Dr Michael A Karp, MD | |
|
100 Hazel Ln, Sewickley, PA 15143-1249 | |
| (412) 749-6806 | |
| Not Available |
| Full Name | Dr Michael A Karp |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 36 Years |
| Location | 100 Hazel Ln, Sewickley, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548286347 | NPI | - | NPPES |
| 0015048990010 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD042695L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concordia Visiting Nurses | Cabot, PA | Home health agency |
| Heritage Valley Sewickley | Sewickley, PA | Hospital |
| Heritage Valley Beaver | Beaver, PA | Hospital |
| Upmc Passavant | Pittsburgh, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Heritage Valley Multispecialty Group Inc | 0042105678 | 235 |
| Keystone Rehabilitation Systems Inc | 7012826753 | 505 |
News Archive
GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its completed Phase 3 Lymphoseek studies in breast cancer and melanoma are being presented at the 32nd Congress of the European Society of Surgical Oncology (ESSO) in Valencia, Spain, from September 19-21, 2012.
Several years ago, University of Michigan researchers published some of the strongest evidence yet that children who snore when they sleep are far more likely to have attention and hyperactivity problems than their non-snoring peers.
Some problems are best solved with new tech or a flashy app. But sometimes adapting existing technology works best of all.
› Verified 2 days ago
| Entity Name | Heritage Valley Multispecialty Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528015401 PECOS PAC ID: 0042105678 Enrollment ID: O20040220000870 |
News Archive
GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its completed Phase 3 Lymphoseek studies in breast cancer and melanoma are being presented at the 32nd Congress of the European Society of Surgical Oncology (ESSO) in Valencia, Spain, from September 19-21, 2012.
Several years ago, University of Michigan researchers published some of the strongest evidence yet that children who snore when they sleep are far more likely to have attention and hyperactivity problems than their non-snoring peers.
Some problems are best solved with new tech or a flashy app. But sometimes adapting existing technology works best of all.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael A Karp, MD 100 Hazel Ln, Sewickley, PA 15143-1249 Ph: (412) 749-6806 | Dr Michael A Karp, MD 100 Hazel Ln, Sewickley, PA 15143-1249 Ph: (412) 749-6806 |
News Archive
GlaxoSmithKline has announced the initiation of a global, open-label, single group trial that will assess the efficacy, safety and tolerability of PROMACTA (eltrombopag olamine) in patients previously treated for chronic idiopathic thrombocytopenic purpura (ITP).
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that data from its completed Phase 3 Lymphoseek studies in breast cancer and melanoma are being presented at the 32nd Congress of the European Society of Surgical Oncology (ESSO) in Valencia, Spain, from September 19-21, 2012.
Several years ago, University of Michigan researchers published some of the strongest evidence yet that children who snore when they sleep are far more likely to have attention and hyperactivity problems than their non-snoring peers.
Some problems are best solved with new tech or a flashy app. But sometimes adapting existing technology works best of all.
› Verified 2 days ago
Dr. Kathleen M Osten, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hazel Ln, Sewickley, PA 15143 Phone: 412-749-6806 Fax: 724-251-9875 | |
Stacey Y Royal, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1106 Ohio River Blvd, # 602, Sewickley, PA 15143 Phone: 419-819-0488 Fax: 412-202-5375 | |
Dr. Janene Hecker Klein, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 720 Blackburn Rd, Sewickley, PA 15143 Phone: 412-749-7076 | |
Benjamin K Boehme, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 100 Hazel Ln Ste 201, Sewickley, PA 15143 Phone: 412-749-6806 | |
Dr. Donna J Craig, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Hazel Ln, Sewickley, PA 15143 Phone: 412-749-0668 | |
Dr. Alexander S. Cone, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 720 Blackburn Rd, Sewickley, PA 15143 Phone: 412-741-6600 |